191 related articles for article (PubMed ID: 11486171)
1. Rosette-forming epithelioid osteosarcoma: a histologic subtype with highly aggressive clinical behavior.
Okada K; Hasegawa T; Yokoyama R
Hum Pathol; 2001 Jul; 32(7):726-33. PubMed ID: 11486171
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
3. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971
[TBL] [Abstract][Full Text] [Related]
4. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
5. Progression of aggressive metastatic carcinosarcoma after treatment of epithelioid osteosarcoma.
Amanatullah DF; Ngann KK; Borys D; Tamurian RM
Orthopedics; 2010 Jun; 33(6):445. PubMed ID: 20806764
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
7. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience.
Mardinger O; Givol N; Talmi YP; Taicher S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Apr; 91(4):445-51. PubMed ID: 11312461
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma with cytokeratin expression: a clinicopathological study of six cases with an emphasis on differential diagnosis from metastatic cancer.
Okada K; Hasegawa T; Yokoyama R; Beppu Y; Itoi E
J Clin Pathol; 2003 Oct; 56(10):742-6. PubMed ID: 14514776
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases--an experience in northern Japan.
Okada K; Hasegawa T; Nishida J; Ogose A; Tajino T; Osanai T; Yanagisawa M; Hatori M
Ann Surg Oncol; 2004 Nov; 11(11):998-1004. PubMed ID: 15525829
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma multidisciplinary approach to the management from the pathologist's perspective.
Raymond AK; Jaffe N
Cancer Treat Res; 2009; 152():63-84. PubMed ID: 20213386
[TBL] [Abstract][Full Text] [Related]
13. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
15. Ezrin expression predicts survival in stage IIB osteosarcomas.
Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
[TBL] [Abstract][Full Text] [Related]
16. Growth patterns of osteosarcoma predict patient survival.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma (osteogenic sarcoma).
Picci P
Orphanet J Rare Dis; 2007 Jan; 2():6. PubMed ID: 17244349
[TBL] [Abstract][Full Text] [Related]
18. Fibular osteosarcomas: contaminated margins may not impact survival.
Schneiderbauer MM; Gullerud R; Harmsen WS; Scully SP
Clin Orthop Relat Res; 2007 Mar; 456():182-7. PubMed ID: 16967031
[TBL] [Abstract][Full Text] [Related]
19. National Cancer Data Base report on osteosarcoma of the head and neck.
Smith RB; Apostolakis LW; Karnell LH; Koch BB; Robinson RA; Zhen W; Menck HR; Hoffman HT
Cancer; 2003 Oct; 98(8):1670-80. PubMed ID: 14534884
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
Benjamin R; Helman L; Meyers P; Reaman G
Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
